The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial (RCT) will be conducted to evaluate the anti-fibrotic
therapeutic effects of resveratrol on the clinical symptoms in discharged COVID-19 patients.